Central Trust Company’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-75
| Closed | -$7K | – | 1201 |
|
|
2021
Q1 | $7K | Buy |
75
+30
| +67% | +$2.8K | ﹤0.01% | 965 |
|
|
2020
Q4 | $4K | Buy |
45
+10
| +29% | +$889 | ﹤0.01% | 989 |
|
|
2020
Q3 | $4K | Sell |
35
-29
| -45% | -$3.31K | ﹤0.01% | 949 |
|
|
2020
Q2 | $5K | Hold |
64
| – | – | ﹤0.01% | 917 |
|
|
2020
Q1 | $4K | Sell |
64
-40
| -38% | -$2.5K | ﹤0.01% | 1002 |
|
|
2019
Q4 | $6K | Sell |
104
-14
| -12% | -$808 | ﹤0.01% | 1025 |
|
|
2019
Q3 | $6K | Sell |
118
-74
| -39% | -$3.76K | ﹤0.01% | 994 |
|
|
2019
Q2 | $8K | Buy |
192
+40
| +26% | +$1.67K | ﹤0.01% | 974 |
|
|
2019
Q1 | $8K | Buy |
152
+32
| +27% | +$1.68K | ﹤0.01% | 936 |
|
|
2018
Q4 | $7K | Sell |
120
-50
| -29% | -$2.92K | ﹤0.01% | 973 |
|
|
2018
Q3 | $11K | Sell |
170
-30
| -15% | -$1.94K | ﹤0.01% | 974 |
|
|
2018
Q2 | $10K | Buy |
+200
| New | +$10K | ﹤0.01% | 975 |
|
|
2017
Q1 | – | Sell |
-30
| Closed | – | – | 1158 |
|
|
2016
Q4 | $0 | Hold |
30
| – | – | ﹤0.01% | 1169 |
|
|
2016
Q3 | $0 | Sell |
30
-1,259
| -98% | – | ﹤0.01% | 1121 |
|
|
2016
Q2 | $36K | Sell |
1,289
-97
| -7% | -$2.71K | ﹤0.01% | 752 |
|
|
2016
Q1 | $50K | Buy |
1,386
+135
| +11% | +$4.87K | ﹤0.01% | 675 |
|
|
2015
Q4 | $50K | Buy |
1,251
+587
| +88% | +$23.5K | ﹤0.01% | 644 |
|
|
2015
Q3 | $19K | Buy |
664
+80
| +14% | +$2.29K | ﹤0.01% | 844 |
|
|
2015
Q2 | $19K | Hold |
584
| – | – | ﹤0.01% | 861 |
|
|
2015
Q1 | $17K | Hold |
584
| – | – | ﹤0.01% | 869 |
|
|
2014
Q4 | $16K | Sell |
584
-44
| -7% | -$1.21K | ﹤0.01% | 876 |
|
|
2014
Q3 | $13K | Buy |
+628
| New | +$13K | ﹤0.01% | 935 |
|